Despite stagnant numbers, there are still a number of profitable product classes in response to the region’s aging population and the rise of non-communicable diseases (NCDs).
Scientists from Argentina and Cuba have developed “Vaxira”, a vaccine against lung cancer which will be commercially available by Elea laboratories from July.
Americas including Argentina, Brazil, Canada, Chile, Colombia, Ecuador, Mexico, Peru, United States, and Venezuela signed an agreement on health ethics in the 2017 Conference on compliance in [...]
The global smart medical devices market was estimated at USD33.7 billion in 2015 and is anticipated to grow at 7.8% to reach USD66.1 billion by 2024. Amongst the smart devices, diagnostic and [...]
Brazil is the largest hospital infrastructure market in Latin America, but remains fragmented. While there are over 7,800 hospitals in the country, the average hospital is relatively small (24 beds).
Latin America is a fast growing healthcare market. The pharmaceutical industry in the region is likely to grow steadily over 2016-2024. The pharmaceutical products and the CMO market in Latin [...]
Ten new genomic institutions from Latin America have started using SOPHiA, the Sophi Genetics’ AI interface in a bid to democratize access to clinical genomics on the continent, and improve [...]
The World Health Organization (WHO) in its latest report has stated that Brazil leads Latin America with the highest number of people suffering from depression (regarding absolute and relative [...]
An international magazine has ranked Costa Rica's healthcare second in the world. Living Magazine studied about the worries of retired Americans living abroad. Healthcare is their number one [...]
Bupa Chile has entered into a cooperation agreement worth EUR 8 millions with Siemens Healthineers in order to make advances in diagnostics in its business units, specifically in IntegraMédica [...]
